Peptides / LL-37

LL-37

(LL-37, Cathelicidin, CAMP)
T3peptidepreclinical

Biomarker Effects

Innate immunity
moderate
Antimicrobial peptide activity
Wound healing
moderate
Promotes tissue repair signaling
Pathogen load
moderate
Direct antimicrobial effects
IL-8
small
Chemotactic immune signaling
CRP
small
Reduces inflammatory burden in infection
Biofilm formation
small
Disrupts microbial biofilms
Skin barrier function
small
Enhances epithelial defense
Neutrophil activity
small
Supports innate immune response

Dosing & Pharmacokinetics

Typical Dose1 mg
Frequencydaily
Routeclinician-directed
Half-Life2 hr

Safety & Evidence

LL-37 is a cathelicidin antimicrobial peptide (CAMP) with immune-modulating, wound healing, and antimicrobial properties. Not FDA-approved.

Sources

Track LL-37 precisely in the Vivy app.

Your precision instrument awaits.

Download Vivy

Related Compounds